2013-02-27 13:36:28 -

MENLO PARK, Calif., February 27, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that Olivia Bloom, Senior Vice President, Finance, and Chief Financial
Officer, will present an overview of the company at 10:40 a.m. Eastern Time on
Wednesday, March 6, at the Cowen and Company 33rd Annual Health Care Conference
in Boston.

A live webcast of the presentation will be available at
 wsw.com/webcast/cowen10/gern/. Following the live presentation, the
webcast will be archived and available for replay at the same address for a
period of 30 days.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat, in clinical development.
For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com  

                                      ###



This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Geron Corp. via Thomson Reuters ONE
[HUG#1681254]